Evidence map›Paper›PMID 26222657›Full record

ArticlePLoS neglected tropical diseases2015

Sequence- and Structure-Based Immunoreactive Epitope Discovery for Burkholderia pseudomallei Flagellin.

Arnone Nithichanon, Darawan Rinchai, Alessandro Gori, Patricia Lassaux, Claudio Peri, Oscar Conchillio-Solé, Mario Ferrer-Navarro, Louise J Gourlay, Marco Nardini, Jordi Vila and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Immune Control ofFrontiers in immunology · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Arnone NithichanonThe Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Darawan RinchaiThe Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Alessandro GoriIstituto di Chimica del Riconoscimento Molecolare, Consiglio Nazionale delle Ricerche, Milan, Italy.
Patricia LassauxDepartment of Biosciences, CIMAINA and CNR Institute of Biophysics, University of Milan, Milan, Italy.
Claudio PeriIstituto di Chimica del Riconoscimento Molecolare, Consiglio Nazionale delle Ricerche, Milan, Italy.
Oscar Conchillio-SoléInstitute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Mario Ferrer-NavarroDepartment of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.
Louise J GourlayDepartment of Biosciences, CIMAINA and CNR Institute of Biophysics, University of Milan, Milan, Italy.
Marco NardiniDepartment of Biosciences, CIMAINA and CNR Institute of Biophysics, University of Milan, Milan, Italy.
Jordi VilaDepartment of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Barcelona, Spain.
Xavier DauraInstitute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Bellaterra, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain.
Giorgio ColomboIstituto di Chimica del Riconoscimento Molecolare, Consiglio Nazionale delle Ricerche, Milan, Italy.
Martino BolognesiDepartment of Biosciences, CIMAINA and CNR Institute of Biophysics, University of Milan, Milan, Italy.
Ganjana LertmemonkolchaiThe Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
University of Milan · ITInstitute of Chemistry of Molecular Recognition · ITKhon Kaen University · THUniversitat de Barcelona · ESInstitució Catalana de Recerca i Estudis Avançats · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkholderia pseudomallei is a Gram-negative bacterium responsible for melioidosis, a serious and often fatal infectious disease that is poorly controlled by existing treatments. Due to its inherent resistance to the major antibiotic classes and its facultative intracellular pathogenicity, an effective vaccine would be extremely desirable, along with appropriate prevention and therapeutic management. One of the main subunit vaccine candidates is flagellin of Burkholderia pseudomallei (FliCBp). Here, we present the high resolution crystal structure of FliCBp and report the synthesis and characterization of three peptides predicted to be both B and T cell FliCBp epitopes, by both structure-based in silico methods, and sequence-based epitope prediction tools. All three epitopes were shown to be immunoreactive against human IgG antibodies and to elicit cytokine production from human peripheral blood mononuclear cells. Furthermore, two of the peptides (F51-69 and F270-288) were found to be dominant immunoreactive epitopes, and their antibodies enhanced the bactericidal activities of purified human neutrophils. The epitopes derived from this study may represent potential melioidosis vaccine components.

Indexed as

Amino Acid SequenceBacterial ProteinsBurkholderia pseudomalleiEpitope MappingEpitopes, B-LymphocyteEpitopes, T-LymphocyteFlagellinHumansLeukocytes, MononuclearMelioidosisMolecular Sequence DataPhagocytosisX-Ray DiffractionBacterial ProteinsEpitopes, B-LymphocyteEpitopes, T-LymphocyteFlagellin

Identifiers

PMID26222657
PMCPMC4519301
OpenAlexW988517819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.